BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

17/09/2021 08:00

Biophytis reports H1 2021 financial results and provides business update

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

15/09/2021 08:00

Biophytis announces DMC second interim analysis efficacy results in the promising zone allowing continuation of phase 2/3 COVA study with Sarconeos (BIO101) in COVID-19

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

14/09/2021 08:00

Biophytis to attend key upcoming investor events and industry conferences

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

09/09/2021 08:00

Biophytis leadership is reinforced with new Chief Medical Officer appointment

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

16/08/2021 08:00

Biophytis Receives Favorable Recommendation From Data Monitoring Committee (DMC) Based on Safety Analysis of Sarconeos (BIO101) to Continue Patient Recruitment in the COVA Study in COVID-19

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

13/08/2021 23:00

Biophytis Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for NEGMA and the Performance of the Judgments of March 16, 2021 and July 16, 2021

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

02/08/2021 08:00

BIOPHYTIS ANNOUNCES TOP LINE RESULTS OF SARA-INT PHASE 2 STUDY WITH SARCONEOS (BIO101) IN SARCOPENIA

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

19/07/2021 23:00

Judgment rendered on July 16, 2021 in the proceedings between Biophytis and Negma Group Ltd by the Execution Judge from the Paris Court of Justice

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

12/07/2021 08:00

Biophytis Presents Positive Preclinical Data on Sarconeos (BIO101) in COVID-19 at ECCMID 2021

Voir tous les communiqués de BIOPHYTIS

BIOPHYTIS (EPA:ALBPS)

08/07/2021 08:00

Biophytis Reinforces Leadership Teams with Three Senior Appointments

Voir tous les communiqués de BIOPHYTIS

1
2
3
4
5
6
7
8
9
10
»